Travere Therapeutics, Inc. Insider Trading for February 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Travere Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Travere Therapeutics, Inc. for February 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 09 2021 | RTRX | Travere Therapeuti ... | Rosenberg Noah L. | Chief Medical Offic ... | Sell | S | 31.58 | 1,125 | 35,528 | 46,344 | 47.5 K to 46.3 K (-2.37 %) |
| Feb 09 2021 | RTRX | Travere Therapeuti ... | Rosenberg Noah L. | Chief Medical Offic ... | Sell | S | 31.41 | 1,125 | 35,336 | 47,469 | 48.6 K to 47.5 K (-2.32 %) |
| Feb 09 2021 | RTRX | Travere Therapeuti ... | Clague Laura | Chief Financial Off ... | Sell | S | 31.58 | 2,250 | 71,055 | 32,223 | 34.5 K to 32.2 K (-6.53 %) |
| Feb 09 2021 | RTRX | Travere Therapeuti ... | Clague Laura | Chief Financial Off ... | Sell | S | 31.41 | 2,250 | 70,673 | 34,473 | 36.7 K to 34.5 K (-6.13 %) |
| Feb 09 2021 | RTRX | Travere Therapeuti ... | Dube Eric M | Chief Executive Off ... | Sell | S | 31.58 | 4,813 | 151,995 | 156,813 | 161.6 K to 156.8 K (-2.98 %) |
| Feb 09 2021 | RTRX | Travere Therapeuti ... | Dube Eric M | Chief Executive Off ... | Sell | S | 31.41 | 4,813 | 151,176 | 161,626 | 166.4 K to 161.6 K (-2.89 %) |
| Feb 05 2021 | RTRX | Travere Therapeuti ... | Rosenberg Noah L. | Chief Medical Offic ... | Grant | A | 0.00 | 4,500 | 0 | 48,594 | 44.1 K to 48.6 K (+10.21 %) |
| Feb 05 2021 | RTRX | Travere Therapeuti ... | Rosenberg Noah L. | Chief Medical Offic ... | Grant | A | 0.00 | 4,500 | 0 | 48,594 | 44.1 K to 48.6 K (+10.21 %) |
| Feb 05 2021 | RTRX | Travere Therapeuti ... | Heerma Peter | Chief Commercial Of ... | Grant | A | 0.00 | 4,500 | 0 | 61,594 | 57.1 K to 61.6 K (+7.88 %) |
| Feb 05 2021 | RTRX | Travere Therapeuti ... | REED ELIZABETH E | SVP, GC & Corporate ... | Grant | A | 0.00 | 4,500 | 0 | 42,205 | 37.7 K to 42.2 K (+11.93 %) |
| Feb 05 2021 | RTRX | Travere Therapeuti ... | Heerma Peter | Chief Commercial Of ... | Grant | A | 0.00 | 4,500 | 0 | 61,594 | 57.1 K to 61.6 K (+7.88 %) |
| Feb 05 2021 | RTRX | Travere Therapeuti ... | Clague Laura | Chief Financial Off ... | Grant | A | 0.00 | 4,500 | 0 | 36,723 | 32.2 K to 36.7 K (+13.97 %) |
| Feb 05 2021 | RTRX | Travere Therapeuti ... | REED ELIZABETH E | SVP, GC & Corporate ... | Grant | A | 0.00 | 4,500 | 0 | 42,205 | 37.7 K to 42.2 K (+11.93 %) |
| Feb 05 2021 | RTRX | Travere Therapeuti ... | Dube Eric M | Chief Executive Off ... | Grant | A | 0.00 | 17,500 | 0 | 166,439 | 148.9 K to 166.4 K (+11.75 %) |
| Feb 05 2021 | RTRX | Travere Therapeuti ... | Clague Laura | Chief Financial Off ... | Grant | A | 0.00 | 4,500 | 0 | 36,723 | 32.2 K to 36.7 K (+13.97 %) |
| Feb 05 2021 | RTRX | Travere Therapeuti ... | Dube Eric M | Chief Executive Off ... | Grant | A | 0.00 | 17,500 | 0 | 166,439 | 148.9 K to 166.4 K (+11.75 %) |
| Feb 03 2021 | RTRX | Travere Therapeuti ... | Heerma Peter | Chief Commercial Of ... | Sell | S | 28.91 | 563 | 16,276 | 57,094 | 57.7 K to 57.1 K (-0.98 %) |
| Feb 03 2021 | RTRX | Travere Therapeuti ... | Heerma Peter | Chief Commercial Of ... | Sell | S | 30.75 | 563 | 17,312 | 57,657 | 58.2 K to 57.7 K (-0.97 %) |
| Feb 03 2021 | RTRX | Travere Therapeuti ... | Rosenberg Noah L. | Chief Medical Offic ... | Sell | S | 28.91 | 563 | 16,276 | 44,094 | 44.7 K to 44.1 K (-1.26 %) |
| Feb 03 2021 | RTRX | Travere Therapeuti ... | Rosenberg Noah L. | Chief Medical Offic ... | Sell | S | 28.91 | 1,250 | 36,138 | 44,657 | 45.9 K to 44.7 K (-2.72 %) |
| Feb 03 2021 | RTRX | Travere Therapeuti ... | ROTE WILLIAM E. | Senior Vice Preside ... | Sell | S | 28.91 | 1,125 | 32,524 | 37,332 | 38.5 K to 37.3 K (-2.93 %) |
| Feb 03 2021 | RTRX | Travere Therapeuti ... | ROTE WILLIAM E. | Senior Vice Preside ... | Sell | S | 28.91 | 2,500 | 72,275 | 38,457 | 41 K to 38.5 K (-6.10 %) |
| Feb 03 2021 | RTRX | Travere Therapeuti ... | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 28.91 | 675 | 19,514 | 37,705 | 38.4 K to 37.7 K (-1.76 %) |
| Feb 03 2021 | RTRX | Travere Therapeuti ... | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 28.91 | 2,500 | 72,275 | 38,380 | 40.9 K to 38.4 K (-6.12 %) |
| Feb 03 2021 | RTRX | Travere Therapeuti ... | Clague Laura | Chief Financial Off ... | Sell | S | 28.91 | 1,125 | 32,524 | 32,223 | 33.3 K to 32.2 K (-3.37 %) |
| Feb 03 2021 | RTRX | Travere Therapeuti ... | Clague Laura | Chief Financial Off ... | Sell | S | 28.91 | 2,500 | 72,275 | 33,348 | 35.8 K to 33.3 K (-6.97 %) |
| Feb 03 2021 | RTRX | Travere Therapeuti ... | Dube Eric M | Chief Executive Off ... | Sell | S | 28.91 | 2,406 | 69,557 | 148,939 | 151.3 K to 148.9 K (-1.59 %) |
| Feb 02 2021 | RTRX | Travere Therapeuti ... | Rosenberg Noah L. | Chief Medical Offic ... | Sell | S | 30.75 | 563 | 17,312 | 45,907 | 46.5 K to 45.9 K (-1.21 %) |
| Feb 02 2021 | RTRX | Travere Therapeuti ... | Rosenberg Noah L. | Chief Medical Offic ... | Sell | S | 30.75 | 1,250 | 38,438 | 46,470 | 47.7 K to 46.5 K (-2.62 %) |
| Feb 02 2021 | RTRX | Travere Therapeuti ... | Rosenberg Noah L. | Chief Medical Offic ... | Grant | A | 0.00 | 5,000 | 0 | 47,720 | 42.7 K to 47.7 K (+11.70 %) |
| Feb 02 2021 | RTRX | Travere Therapeuti ... | ROTE WILLIAM E. | Senior Vice Preside ... | Sell | S | 30.75 | 1,125 | 34,594 | 43,457 | 44.6 K to 43.5 K (-2.52 %) |
| Feb 02 2021 | RTRX | Travere Therapeuti ... | ROTE WILLIAM E. | Senior Vice Preside ... | Sell | S | 30.75 | 2,500 | 76,875 | 40,957 | 43.5 K to 41 K (-5.75 %) |
| Feb 02 2021 | RTRX | Travere Therapeuti ... | ROTE WILLIAM E. | Senior Vice Preside ... | Grant | A | 0.00 | 5,000 | 0 | 44,582 | 39.6 K to 44.6 K (+12.63 %) |
| Feb 02 2021 | RTRX | Travere Therapeuti ... | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 30.75 | 675 | 20,756 | 40,880 | 41.6 K to 40.9 K (-1.62 %) |
| Feb 02 2021 | RTRX | Travere Therapeuti ... | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 30.75 | 2,500 | 76,875 | 41,555 | 44.1 K to 41.6 K (-5.67 %) |
| Feb 02 2021 | RTRX | Travere Therapeuti ... | REED ELIZABETH E | SVP, GC & Corporate ... | Grant | A | 0.00 | 5,000 | 0 | 44,055 | 39.1 K to 44.1 K (+12.80 %) |
| Feb 02 2021 | RTRX | Travere Therapeuti ... | Dube Eric M | Chief Executive Off ... | Sell | S | 30.75 | 2,406 | 73,985 | 151,345 | 153.8 K to 151.3 K (-1.56 %) |
| Feb 02 2021 | RTRX | Travere Therapeuti ... | Dube Eric M | Chief Executive Off ... | Sell | S | 29.60 | 6,328 | 187,282 | 153,751 | 160.1 K to 153.8 K (-3.95 %) |
| Feb 02 2021 | RTRX | Travere Therapeuti ... | Dube Eric M | Chief Executive Off ... | Grant | A | 0.00 | 15,000 | 0 | 160,079 | 145.1 K to 160.1 K (+10.34 %) |
| Feb 02 2021 | RTRX | Travere Therapeuti ... | Clague Laura | Chief Financial Off ... | Sell | S | 30.75 | 1,125 | 34,594 | 35,848 | 37 K to 35.8 K (-3.04 %) |
| Feb 02 2021 | RTRX | Travere Therapeuti ... | Clague Laura | Chief Financial Off ... | Sell | S | 30.75 | 2,500 | 76,875 | 36,973 | 39.5 K to 37 K (-6.33 %) |
| Feb 02 2021 | RTRX | Travere Therapeuti ... | Clague Laura | Chief Financial Off ... | Grant | A | 0.00 | 5,000 | 0 | 39,473 | 34.5 K to 39.5 K (+14.50 %) |
| Feb 02 2021 | RTRX | Travere Therapeuti ... | ASELAGE STEVE | Director | Option Exercise | M | 10.09 | 25,000 | 252,250 | 275,000 | |
| Feb 02 2021 | RTRX | Travere Therapeuti ... | ASELAGE STEVE | Director | Sell | S | 30.75 | 25,000 | 768,750 | 196,667 | 221.7 K to 196.7 K (-11.28 %) |
| Feb 02 2021 | RTRX | Travere Therapeuti ... | ASELAGE STEVE | Director | Buy | M | 10.09 | 25,000 | 252,250 | 221,667 | 196.7 K to 221.7 K (+12.71 %) |